Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Kathryn A. Gibson"'
Autor:
Nicholas Rodwell, Geraldine Hassett, Paul Bird, Theodore Pincus, Joseph Descallar, Kathryn A. Gibson
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 10, Pp 511-521 (2023)
Objective To analyze a RheuMetric checklist, which includes four feasible physician 0 to 10 scores for DOCGL, inflammation (DOCINF), damage (DOCDAM), and distress (DOCSTR) for criterion and discriminant validity against standard reference measures. M
Externí odkaz:
https://doaj.org/article/34888b9da60b4973844747ce82b603e5
Autor:
Sabina Ciciriello, Geoffrey Littlejohn, Tamas Treuer, Kathryn A. Gibson, Ewa Haladyj, Peter Youssef, Paul Bird, Catherine O'Sullivan, Tegan Smith, Claire T. Deakin, OPAL Rheumatology
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 7, Pp 345-353 (2023)
Objective To analyze comparative treatment persistence for first‐line baricitinib (BARI) versus first‐line tumor necrosis factor inhibitor (TNFi) in patients with rheumatoid arthritis (RA) and for first‐line BARI initiated as monotherapy versus
Externí odkaz:
https://doaj.org/article/4d2c347dcd0d4556b637deb60b95cc9a
Autor:
Rangi Kandane-Rathnayake, Worawit Louthrenoo, Alberta Hoi, Shue-Fen Luo, Yeong-Jian J. Wu, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Sandra V. Navarra, Leonid Zamora, Sargunan Sockalingam, Yuan An, Zhanguo Li, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, Jun Kikuchi, Tsutomu Takeuchi, B. M. D. B. Basnayake, Madelynn Chan, Kristine Pek Ling Ng, Nicola Tugnet, Sunil Kumar, Shereen Oon, Fiona Goldblatt, Sean O’Neill, Kathryn A. Gibson, Naoaki Ohkubo, Yoshiya Tanaka, Sang-Cheol Bae, Chak Sing Lau, Mandana Nikpour, Vera Golder, Eric F. Morand, For the Asia-Pacific Lupus Collaboration
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-10 (2022)
Abstract Background The unmet need in systemic lupus erythematosus (SLE) with the current standard of care is widely recognised, but few studies have quantified this. The recent definition of treat-to-target endpoints and other thresholds of uncontro
Externí odkaz:
https://doaj.org/article/461787ebe7cb4251a2a681718deb19b6
Autor:
Theodore Pincus, Kathryn A. Gibson
Publikováno v:
Current Treatment Options in Rheumatology. 7:161-181
Purpose of Review To update the clinical value of a patient self-report multidimensional health assessment questionnaire (MDHAQ). Recent Findings The MDHAQ includes 10 individual quantitative scores for physical function, pain, patient global assessm
Autor:
Kathryn Connelly, Rangi Kandane‐Rathnayake, Alberta Hoi, Worawit Louthrenoo, Laniyati Hamijoyo, Shue Fen Luo, Yeong‐Jian Jan Wu, Jiacai Cho, Aisha Lateef, CS Lau, Yi‐Hsing Chen, Sandra Navarra, Leonid Zamora, Zhanguo Li, Yuan An, Sargunan Sockalingam, Yanjie Hao, Zhuoli Zhang, Madelynn Chan, Yasuhiro Katsumata, Masayoshi Harigai, Shereen Oon, Sang‐Cheol Bae, Sean O'Neill, Kathryn A. Gibson, BMDB Basnayake, Jun Kikuchi, Tsutomu Takeuchi, Kristine Pek Ling Ng, Nicola Tugnet, Sunil Kumar, Fiona Goldblatt, Annie Law, Michael Tee, Cherica Tee, Yoshiya Tanaka, Naoaki Ohkubo, Jin Yu Tan, Chetan S. Karyekar, Mandana Nikpour, Vera Golder, Eric F. Morand
Publikováno v:
Arthritisrheumatology (Hoboken, N.J.)REFERENCES.
In trials of systemic lupus erythematosus (SLE), the SLE Responder Index (SRI) is the most commonly used primary efficacy end point but has limited validation against long-term outcomes. We aimed to investigate associations of attainment of a modifie
Publikováno v:
Seminars in Arthritis and Rheumatism. 58:152151
Patient global assessment (PATGL) is a component of rheumatoid arthritis (RA) and spondyloarthritis (SpA) activity indices, reflecting inflammation in selected clinical trial patients. In routine care, PATGL often may be elevated independently of inf
Publikováno v:
JMIR Cancer
Background Therapeutic decision-making in oncology is a complex process because physicians must consider many forms of medical data and protocols. Another challenge for physicians is to clearly communicate their decision-making process to patients to
BACKGROUND Therapeutic decision-making in oncology is a complex process because physicians must consider many forms of medical data and protocols. Another challenge for physicians is to clearly communicate their decision-making process to patients to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7bba2f02161750c697a87d0ef1960dd
https://doi.org/10.2196/preprints.31616
https://doi.org/10.2196/preprints.31616
Autor:
Kathryn A. Gibson, Theodore Pincus
Publikováno v:
Oxford Textbook of Rheumatoid Arthritis
A patient history is far more prominent in diagnosis and management of rheumatoid arthritis (RA) than in many chronic diseases, such as hypertension and diabetes, in which biomarkers dominate clinical decisions. A patient history traditionally has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2396cb4d63f330b8c34b6078bd3bd84
https://doi.org/10.1093/med/9780198831433.003.0020
https://doi.org/10.1093/med/9780198831433.003.0020
Autor:
Jeanette M. Thom, Sarah Dennis, Rebecca Livings, Siobhan M Schabrun, Justine M. Naylor, Kathryn Mills, Kathryn A. Gibson
Publikováno v:
BMJ Open
BMJ Open, Vol 10, Iss 7 (2020)
BMJ Open, Vol 10, Iss 7 (2020)
IntroductionThere is a gap between the care people with knee osteoarthritis (OA) should receive according to evidence-based guidelines and the care they do receive. This feasibility study aims to test the feasibility of developing and implementing a